KRISTEN RYAN LARREA
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SAN DIEGO, CA NPI 1720451644
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CA NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$3,471.42
- Category: General Payments
- Program years: PY2021–2024
- Record count: 136
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,281.98 across 51 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,281.98 | 51 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $197.49 | 8 |
| Merck Sharp & Dohme Corporation | $101.74 | 4 |
| Daiichi Sankyo Inc. | $99.03 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $95.73 | 3 |
| Acerta Pharma LLC | $89.88 | 3 |
| Regeneron Healthcare Solutions, Inc. | $69.75 | 3 |
| EISAI INC. | $66.29 | 3 |
| Ipsen Biopharmaceuticals, Inc | $59.22 | 2 |
| Celgene Corporation | $45.04 | 2 |
| AVEO Pharmaceuticals, Inc. | $44.08 | 2 |
| ABBVIE INC. | $42.24 | 2 |
| PFIZER INC. | $40.92 | 2 |
| Gilead Sciences, Inc. | $34.66 | 1 |
| Alexion Pharmaceuticals, Inc. | $33.69 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $30.60 | 1 |
| Janssen Biotech, Inc. | $29.04 | 1 |
| BeiGene USA, Inc. | $27.82 | 1 |
| Sumitomo Pharma America, Inc. | $24.84 | 1 |
| Coherus Biosciences Inc. | $24.32 | 1 |
| Incyte Corporation | $23.16 | 1 |
| EMD Serono, Inc. | $21.93 | 1 |
| Genmab U.S., Inc. | $21.50 | 1 |
| E.R. Squibb & Sons, L.L.C. | $20.95 | 1 |
| SOBI, INC | $19.91 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $18.15 | 1 |
By program year
Records — PY2024 (51)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.